姓名：吳美貌

族群：漢族

現在的職務：
1、「生技中心」商務發展組原住民產業發展副研究員
2、「台灣世界展望會」社區產業發展諮詢委員。

主要工作經驗：
1、農用生物製劑：蘇力菌、枯草桿菌、菌根菌、溶磷菌、蟲生線蟲等
醱酵產程開發、應用與推廣 (1993-迄今) 。
2、東吳大學微生物學系客座講師 (2005) 。
3、大葉工學院食品工程系兼任講師(2000-2002) 。

工作理念和對未來的期待：
透過農業生物應用技術平台及田間管理經驗，協助部落建立科學化管理知識與技術，發展具有競爭力的農業產業。藉由產業發展開拓生活領域，從基本生存需求延伸至生活開發與生態環境保護及傳統文化保留，以促進部落整體經濟繁榮。再透過相關組織串聯與合作，協力建構原住民主體價值網絡，期待不久將來，社區群體自行持續穩定發展並分享成功經驗，以建立獨立自主生活。

財團法人生物技術開發中心

設立緣起
財團法人生物技術開發中心(簡稱生技中心, Development Center for Biotechnology, DCB)，成立於民國73年，為經濟部指導下之非營利事業組織。

服務對象
配合產、官、學、研各界，致力發展台灣生技產業，開發關鍵生物技術並負責產業所需的重要環境建構及專業人才培植、延攬。目前致力的五大核心發展領域，包括:﹙1﹚蛋白質藥物；﹙2﹚小分子新藥；﹙3﹚基因藥物；﹙4﹚中草藥開發；﹙5﹚環境生物技術研發。

宗旨與目標
﹙1﹚ 開發生物技術，以期達到國際水準，貢獻人類。
﹙2﹚ 推動國內生技產業，促進產業升級。
﹙3﹚ 建立研發技術平台，執行中心新藥開發及產業所需之研發服務。
﹙4﹚ 生技藥品生產技術、仿效藥、新療效及新中草藥之開發。

主要任務
積極協助台灣生技產業加速發展，創造廣大商機，在產品商業化及研發工作上，生技中心均協助提供多項服務，與台灣生技產業共同努力，提供業界學界迅速、便利之國內外生物研發技術及市場諮詢服務，落實政府期望逐步邁向全球市場，發揮生技中心特色及服務產業之精神。

聯絡資訊
http://www.dcb.org.tw/



ABOUT DCB
The Development Center for Biotechnology (DCB) is a nonprofit organization founded in 1984 for research and development (R&D) in biotechnology. It plays the role of flagship for Taiwan’s biotech industry, and is bestowed with the mission to promote Taiwan’s biotechnology development through researching biosciences, developing technologies, building infrastructures, training professionals, catalyzing synergy of governmental, academic and industrial endeavors in biotechnology, and bridging Taiwan’s biotech industry with international R&D communities.
We are currently focused on four major areas: (1) environmental biotechnology; (2) herbal medicines; (3) pharmaceuticals, including small-molecule drugs and new formulation development; (4) biopharmaceuticals, including monoclonal antibodies, recombinant proteins and vaccines. At present, the disease categories selected for drug development at DCB are cancers, diabetes and infectious diseases.
HUMAN RESOURCES
The DCB has an elite group of scientists and an efficient support staff dedicated to the development and research objectives. Out of the 400 employees, 85% possess academic degrees, including 91 Ph.D's, 162 MSc's, and 66 BSc's.
HISTORY
(1) 1984~1986: The DCB d eveloped Taiwan’s biotechnology industry, by planning development strategies and goals. We succeeded in attracting biotech elites and trained professionals in this field and applications in agricultural、special chemical, and environment protection.
(2) 1987~1990: The DCB established core technologies and R&D processes focused on transfer of key technologies. By this time, the government had established a 6-year national multi-industry construction program and contributed to ten other innovative industries. We were responsible for the development and strengthening of pharmaceutical R&D programs, medical health care technologies, and pollution prevention initiatives used to develop other technical and industrial applications.
(3) 1991~ Present: The Taiwan Government has focused on its biotech policies supporting commercialization. During this period, the DCB has firmed up its biotechnology applications in pharmaceutical, agriculture, special chemical, and environment protection divisions. The DCB has continued to collaborate with local companies by training R&D specialists serving for Taiwanese companies and using technology transfer to spur domestic industries with the hope of upgrading the local biotech industry in the face of international competition.
FORWARD
First, the DCB vertically links the academic sector with the industrial sector through the promotion of applied scientific technology. We emphasize the consolidation of advanced technologies and resources and the exploration of opportunities for product development. Our pilot plants develop technologies derived from academic research and subsequently transfer them to private industry in order to reduce their R&D costs.
Second, the DCB horizontally adapts suitable biotechnologies from around the world and transfers them to domestic industries. For the final phase of commercialization, projects are selected based on conformity with market needs and direct participation of industrial partners. This is to help Taiwanese companies uphold their product advantages in the face of international competition. In addition to laboratory facility access, the DCB also offers consulting services on market and industrial information research for domestic and overseas enterprises, academic institutes, and government agencies.
http://www.dcb.org.tw/

今天我們進行了第五次的行前會議。
由於颱風的影響，江瑛被困在霧台的山上，
建治和哈露谷跑去做別的事了，
所以少了三個人的參與。

不過我們還是很努力地把行前的部份都討論過一次，
也決定少開一次行前會，
要出國十一天的我們，每個人都會很忙，
所以只好靠網路來溝通事情囉！


觀看全文...